Research Use Disclaimer The compounds distributed by USA PEPTIDE SCIENCES , including the BPC-157, TB-500, GHK-Cu 30mg (Glow Blend) research vials, are designated strictly for laboratory research purposes only
Boosts fat metabolism
Contraindications Administration to animals with vitamin E deficiency
Tirzepatide holds FDA approvals as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well
Technical and internet activity: IP address, browser, device, operating system, referring pages, pages visited, approximate location derived from IP, timestamps, cookies, local storage, and security logs
Research facilities equipped to handle, extract, and store synthetic compounds under appropriate laboratory conditions